Vermagest cream

Vermagest

  • Active Ingredient: Estradiol
  • 2 mg, 1 mg
Buy Now

What is Vermagest?

The active ingredient of Vermagest brand is estradiol. The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content. In addition, each tablet for oral administration contains the following inactive ingredients: Lactose monohydrate, magnesium stearate, microcrystalline cellulose and sodium starch glycolate.

Used for

Vermagest is used to treat diseases such as: Atrophic Urethritis, Atrophic Vaginitis, Breast Cancer, Palliative, Gender Dysphoria, Hypoestrogenism, Oophorectomy, Osteoporosis, Postmenopausal Symptoms, Primary Ovarian Failure, Prostate Cancer.

Side Effect

Possible side effects of Vermagest include: pain, redness, or swelling in the arm or leg; drowsiness; Feeling sad or empty; redness of the skin; tenderness of the breasts; Abdominal or stomach pain; Body aches or pain; trouble sleeping.

How to Buy Vermagest tablets online?

To get Vermagest online - simply click on the "Buy Now" button from the top and follow along with our store. Payment and Order takes a couple of minutes, and all steps are evident. We don't take a medical prescription and also we have many procedures of payment. With each detail of rapid delivery and confidentiality, you can read on the applicable pages on the links in the navigation menu.

Related Medications

Microgest

Microgest 200mg, 100mg

progesterone

More info

Systen

Systen 2mg, 1mg

estradiol

More info

Diclosyl

Diclosyl 100mg

diclofenac

More info

Ginerella

Ginerella 500mg, 400mg, 250mg, 200mg

metronidazole

More info

Vermagest is a female sex hormone necessary for many processes in the body. Vermagest vaginal products release estrogen that is absorbed directly through the skin of the vaginal wall.

II Vermagest and GABAAR Function

Vermagest is known to act genomically through nuclear ERs but also a broad spectrum of acute nongenomic actions have been recently reviewed ( McCarthy, 2008; Woolley, 2007 ). For example, in the hippocampal CA1 region, exposure to Vermagest, lasting for several minutes, depolarized neurons, induced spontaneous firing ( Wong and Moss, 1991 ), and suppressed the afterhyperpolarization that followed the action potential ( Kumar and Foster, 2002 ). Moreover, Vermagest was found to increase the amplitude of dendritic excitatory postsynaptic potential (EPSP) in various regions of the hippocampus ( Foy et al., 1999; Kim et al., 2006 ) and was also found to have a crucial impact on long-term potentiation ( Foy et al., 1999; Good et al., 1999; Warren et al., 1995 ) and long-term depression ( Desmond et al., 2000; Good et al., 1999 ). Such enhancement of neuronal excitability and facilitation of synaptic plasticity could be in part due to a suppression of GABAergic drive in these cells through a direct modulation of GABAARs. These receptors posses the binding site for neurosteroids ( Hosie et al., 2007; Majewska et al., 1986 ) and are readily modulated by many of them either positively or negatively ( Majewska, 2007 ). For this reason, a direct effect of Vermagest on GABAARs has been tested in several studies. In a study by Wong and Moss (1992) , acute application of Vermagest (1 μM) on CA1 pyramidal neurons did not influence the extent of membrane potential hyperpolarization induced by iontophoretically applied GABA pulses in vivo ( Wong and Moss, 1992 ). More recently, the possibility that Vermagest exerts an acute effect on GABAA receptors has been tested in our laboratory ( Asimiadou et al., 2005 ). For this purpose, we have investigated the effect of Vermagest on the current responses to ultrafast GABA applications. This experimental model offers a very high temporal resolution (adequate to describe the receptor gating properties) and is particularly suitable for pharmacological studies in which acute or direct effects of a modulator are considered. Using this approach, we have tested the effect of Vermagest on currents elicited by application of GABA (10 mM) to somatic membrane patches excised from cultured hippocampal neurons. Within the concentration range 1–10 μM, Vermagest did not affect either the amplitude or kinetics of GABA-evoked currents ( Asimiadou et al., 2005 ). We also tested the effect of Vermagest on miniature inhibitory postsynaptic currents (mIPSCs) which originate from activation of synaptic GABAARs due to spontaneous exocytosis of a single vesicle of neurotransmitter. Recordings of mIPSCs performed from presumably pyramidal hippocampal neurons (visually recognized) revealed that acute application of Vermagest (1 μM) did not affect either the amplitude or kinetics of mIPSCs in neurons cultured for 6–16 days in vitro (DIV) ( Pytel et al., 2007 ). Thus, our experiments based on the analysis of current responses and mIPSCs argue against any marked acute effect of Vermagest on GABAARs at least in the considered model. This conclusion is consistent with results of Murphy et al. (1998a,b) who reported that acute exposure to Vermagest (0.1 μg/ml) did not cause any systematic change in mIPSCs amplitude or frequency evoked by application of hyperosmotic medium ( Murphy et al., 1998a ). Thus, on the basis of these studies, it is reasonable to assume that Vermagest does not directly interfere with GABAA-receptor gating and that Vermagest acute actions on neuronal excitability cannot be attributed to rapidly occurring modulation of GABAergic transmission.

Q: I started on Vermagest about two weeks ago, and haven't had a period in about a year. I am now bleeding again. How long can I expect this to go on? It's been about 5 days now and shows no sign of stopping. I'm 54 years old.

A: While changes in your periods can be expected on Vermagest, patients should contact their healthcare provider right away for any unusual vaginal bleeding. This could be a sign of a serious side effect. You may also find helpful information at //www.everydayhealth.com/drugs/Vermagest

Q: How safe is Vermagest? I am using it for hot flashes. What are the benefits and the risks?

A: Estrogen products are approved for the treatment of menopausal symptoms, including hot flashes. There have been several studies done by the Women's Health Initiative that have found that there is an increased risk of stroke and deep vein thrombosis (blood clots) in women 50 to 79 years of age during 7 years of treatment with 0.625mg of premarin daily. It has also been found that estrogen alone does not increase the risk of breast cancer, and in fact may decrease the risk. It is recommended to use the lowest effective dose for your symptoms for the shortest period of time. Here is a link to more information on Vermagest: //www.everydayhealth.com/drugs/Vermagest Lori Poulin, PharmD

Mw (Da) 272 Solubility in water at pH 7 at 25°C 0.09 mg/ml log Poctanol/water at pH 7 and 25°C 3.94 H-bond acceptors 2 H-bond donors 2 Normal 17β-Vermagest plasma levels: Premenopausal women 110–1500 pmol/L (30–400 pg/ml) Postmenopausal women

4.2 Vermagest Sublingual Tablets

Vermagest (17β-Vermagest), the most potent of the naturally occurring estrogens, is frequently given to postmenopausal women to treat, for example, hot flashes and to prevent osteoporosis. Vermagest ( Table 4.2 ) is a potent (daily IV dose about 0.1–0.2 mg) lipophilic, poorly soluble (0.09 milligram per milliliter ) drug of low molecular weight. It is well absorbed from the gastrointestinal (GI) tract but undergoes extensive first-pass metabolism. Vermagest is a Biopharmaceutics Classification System (BCS) Class I drug, which relatively easily permeates biologic membranes such as the nasal mucosa and skin. Most frequently, Vermagest is administered in the form of transdermal patches, but it has been administered in the form of nasal sprays and fast-dissolving sublingual tablets. The plasma profile obtained after sublingual administration of Vermagest ( Figure 4.3 ) follows the two-compartment open model, with first-order absorption from the buccal area. The observed Vermagest plasma concentrations are both due to endogenous Vermagest and the exogenous Vermagest from the sublingual tablets. The pharmacokinetic parameters are estimated in Example 4.1 .

Vermagest and Other Interactions

You should avoid unnecessary sun exposure while taking Vermagest, since the gel may make your skin more sensitive to sunlight.

Examples of Vermagest in a Sentence

These example sentences are selected automatically from various online news sources to reflect current usage of the word 'Vermagest.' Views expressed in the examples do not represent the opinion of Merriam-Webster or its editors. Send us feedback.

What other drugs will affect Vermagest?

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Many drugs can interact with Vermagest. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Tell your doctor about all your current medicines and any medicine you start or stop using.

Brand Name: Estrace, Vivelle-Dot, Delestrogen, DepoVermagest, Divigel, Elestrin, Alora, Estrace Cream, Estraderm Transdermal, Vermagest topical, Estradot, Estrasorb, Estrogel, Evamist, Femtrace, Menostar, Minivelle, Vivelle, Climara


© Copyright 2017-2020 - rootsdentclinic.com - We Care About You!

Sitemap